DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Wiestner A.
Targeting B-Cell Receptor Signaling for Anticancer Therapy: The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Induces Impressive Responses in B-Cell Malignancies.
J Clin Oncol 2013;
31: 128-130
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.